OBJECTIVE To evaluate skin perfusion in cats receiving dexmedetomidine compared to a placebo. ANIMALS 9 healthy adult research cats. METHODS A randomized, blinded, placebo-controlled study design was used. Two sites, the dorsal metatarsus (site: limb) and lateral flank (site: flank), were evaluated with laser speckle contrast imaging (LSCI) at baseline and following admin-istration of dexmedetomidine (1, 3, or 5 mcg/kg, IV) or a placebo (0.9% saline, IV). Mean speckle contrast (MSC), a surrogate for perfusion, was obtained from LSCI and compared between treatments. Heart rate, sedation score, and body temperature were recorded. Skin perfusion to the flank and limb, reported as MSC, was assessed via LSCI at baseline and at 5, 10, and 15 minutes posttreatment. RESULTS There was a significant decrease in heart rate (P
CITATION STYLE
Hollenbeck, D. L., Simon, B. T., Scallan, E. M., Thieman-Mankin, K. M., Miller, D. R., Dunn, A. K., & Dickerson, V. M. (2023). Sedation with dexmedetomidine decreases skin perfusion in cats. American Journal of Veterinary Research, 84(12). https://doi.org/10.2460/ajvr.23.06.0137
Mendeley helps you to discover research relevant for your work.